Regeneron Pharmaceuticals, Inc. (REGN)

543.56
NASDAQ
Prev Close 555.79
Day Low/High 533.23 / 556.58
52 Wk Low/High 303.49 / 664.64
Exchange NASDAQ
Shares Outstanding 106.39B
Market Cap 59.13B
P/E Ratio 21.54
Div & Yield N.A. (N.A)

I'm Going to Keep Riding These Horses

Biogen miss no reason to abandon big 4 of Big Pharma.

Mylan Deal the Rx for Drug Stocks

Mylan Deal the Rx for Drug Stocks

Even the second-tier biotechs are taking off.

Biotech Investors: Buy In or Get Out

No more hand-holding on these names.

Portfolio Managers Shop for Growth

Combined Heinz-Kraft heads a long second-quarter list.

Answering Your Tweets

An answer to those asking me what's worth buying.

Biotech, Chips Stand Their Ground

You can't help but feel better about both groups.

Biotechs Need to Rest

If there is no catalyst, I'd join those who sell on a bounce.

Backing Away From Biotechs

This sector could see some real damage.

The 7 Pillars of Healthcare Strength

The 7 Pillars of Healthcare Strength

Here are healthcare stocks of all shares and sizes with strong charts.

Biotech Stocks at a Crossroad

Own them, or take something off the table?

I'm Making a Don't-Buy Call on Biotech

I'm Making a Don't-Buy Call on Biotech

I really like the stocks. But I also like making money on stocks.

The Next Biotech Breakout?

As always, I am happy to be standing in for Doug Kass today on the Daily Diary (this Friday from sunny Miami). It looks like it will be an up open to talk about based on early market futures. The euro is heading towards its best week in 18 months, e...

These Stocks Get Benefit of the Doubt

Market backtracks on skepticism over biotechs.

Remarkable Biotech Runs Continue

Remarkable Biotech Runs Continue

A Fed-related dip may be your only hope to get in lower.

What Is Wrong With You People?

What Is Wrong With You People?

These companies are doing great -- take some profits!

Blame It (or Much of It) on the Dollar

Blame It (or Much of It) on the Dollar

What if you make a move and the Fed wrecks it?

2 Biotechs That Still Offer Value

2 Biotechs That Still Offer Value

Amgen and Gilead shine in one of the market's best-performing sectors.

Market Rewards Biotech Latecomers

It shouldn't be possible, but it never seems too late to get in.

That's Just What's Supposed to Happen

Stocks that stabilized yesterday were terrific today.

The Biotechs Are Feeling Better

The Biotechs Are Feeling Better

Sector could regain its leadership role.

The Biotechs Are Back

Watch this leadership group that's been lagging.

Violent Moves in a 'Scarface' Market

The 'dead bodies' are adding up.

8 Signs the Market Is Remarkably Healthy

These are surefire indications of a bountiful tape.

A Tasty Reversal With 6 Key Ingredients

But tomorrow we hear from the banks.

Braving Biotech

Do you need to pick one name? Biotech has carried with it a lasting resiliency like few other sectors. Perhaps it is driven by optimism and hope. Perhaps it is driven by the fear of suffering or watching someone suffer from the very illnesses these ...

Regeneron upgraded at Morgan Stanley

Go With What's Worked, Part 1

Throughout this historic run, four groups have consistently led the market.

Absolutely Nothing Happened

There had been no catalysts.

Cramer: Oil-and-Gas vs. Everything Else

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

There's a Lot Going on Under the Hood

An immense market rotation is happening.